← Back to search results

plannedFind a Tender · planning

Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine

Buyer: ANIMAL AND PLANT HEALTH AGENCY →

BuyerANIMAL AND PLANT HEALTH AGENCY
Statusplanned
DeadlineNot published
Value£4,500,000
Published8 Aug 2025

What is being bought

Defra is exploring options for supply of antigen and vaccines to the UK foot and mouth disease (FMD) vaccine bank and is seeking to identify existing and potential suppliers who have FMD vaccines with robust evidence of quality, safety, and efficacy. We are keen to hear from suppliers who are in a position to supply suitable FMD vaccine products from early 2027 (including manufacturing lead times as necessary). Please provide the information detailed in the section below, but please note that Defra will not consider heterologous vaccine products. Those wishing to provide the information requested here should contact Melanie Swain (melanie.swain@defra.gov.uk), by the 8 September 2025. Defra reserves the right to follow up with suppliers on a 1:1 basis to further understand their capabilities with regard to this requirement. Defra is seeking this information to inform decisions around guarantees of supply to the UK market. Therefore the estimated total value shown below is only indicative at this stage.

Delivery location

UK, GB

Categories

Vaccines for veterinary medicine 33651690

Lot details

Lot 1

No lot description published.

Statusplanned
Contract periodFrom 1 Apr 2026 to 31 Dec 2031
SME suitabilitySuitable for SMEs

What is included

ItemCategoryQuantity
1Vaccines for veterinary medicineNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Vaccines for veterinary medicine (33651690); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 332,1442 median · 92.4 average (783 of 2,144 with a bid count)6 average (908 of 2,144 with named award suppliers)Not published
Same buyer4Not publishedNot publishedNot published
Delivery region: UK53814 median · 286.8 average (167 of 538 with a bid count)13 average (198 of 538 with named award suppliers)Not published
Similar published value (0.5×–2×)18856.5 median · 56.5 average (2 of 188 with a bid count)8.5 average (2 of 188 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetValue not published
No-engagement rationaleNot published
Planning documents1
Planning milestones1
MilestoneTypeDueStatus
If your organisation is interested in this requirement, please provide the following information to the named contact above, via email: - The details of your organisation's FMD antigen and vaccine products. - Number and size of dose. - Data on safety, efficacy and period (onset and duration) of immunity in the target species. - Longevity/shelf life of vaccines and antigen. - The number of doses in the vaccination schedule. - Storage conditions and bottle sizes available. - The type of technology used to develop the vaccine production capacity. - Species that can be vaccinated and any data on the minimum age that animals can be vaccinated. - Whether the vaccine is produced to GMP standard or equivalent. - Whether the vaccine is manufactured and stored according to the WOAH Terrestrial Manual Chapter 3.1.8. - Whether the vaccine is currently authorised for use with a valid marketing authorisation and, if so, where is the vaccine authorised. - Whether the vaccine has been used elsewhere in the world. - Timelines for submitting applications for a marketing authorisation to VMD (if relevant). - The likely cost of the product. - Information on novel technologies and products and likely timeframe to market.engagement8 Sept 2025scheduled

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-0583a6
Latest release ID047118-2025
Latest release timestampFri Aug 08 2025 07:56:20 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanned
Procurement methodNot published
Procurement method detailsNot published
Main procurement categorygoods
Above thresholdYes
Legal basis2023/54
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender value£4,500,000
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release2

Notice history

DateEventReference
8 Aug 2025planning047118-2025
7 Aug 2025planning047030-2025

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "047118-2025",
  "tag": [
    "planning"
  ],
  "date": "2025-08-08T08:56:20+01:00",
  "ocid": "ocds-h6vhtk-0583a6",
  "buyer": {
    "id": "GB-PPON-PBHC-6261-BLLQ",
    "name": "ANIMAL AND PLANT HEALTH AGENCY"
  },
  "tender": {
    "id": "P37007",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "hasRenewal": true,
        "suitability": {
          "sme": true
        },
        "contractPeriod": {
          "endDate": "2031-12-31T23:59:59Z",
          "startDate": "2026-04-01T00:00:00+01:00",
          "maxExtentDate": "2036-12-31T23:59:59Z"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33651690",
            "scheme": "CPV",
            "description": "Vaccines for veterinary medicine"
          }
        ]
      }
    ],
    "title": "Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine",
    "value": {
      "amount": 4500000,
      "currency": "GBP",
      "amountGross": 5400000
    },
    "status": "planned",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "Defra is exploring options for supply of antigen and vaccines to the UK foot and mouth disease (FMD) vaccine bank and is seeking to identify existing and potential suppliers who have FMD vaccines with robust evidence of quality, safety, and efficacy. We are keen to hear from suppliers who are in a position to supply suitable FMD vaccine products from early 2027 (including manufacturing lead times as necessary). Please provide the information detailed in the section below, but please note that Defra will not consider heterologous vaccine products. Those wishing to provide the information requested here should contact Melanie Swain (melanie.swain@defra.gov.uk), by the 8 September 2025. Defra reserves the right to follow up with suppliers on a 1:1 basis to further understand their capabilities with regard to this requirement. Defra is seeking this information to inform decisions around guarantees of supply to the UK market. Therefore the estimated total value shown below is only indicative at this stage.",
    "communication": {
      "futureNoticeDate": "2025-11-21T23:59:59Z"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PBHC-6261-BLLQ",
      "name": "ANIMAL AND PLANT HEALTH AGENCY",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI32",
        "country": "GB",
        "locality": "London",
        "postalCode": "SW1P 4DF",
        "countryName": "United Kingdom",
        "streetAddress": "Seacole Building, 2 Marsham Street"
      },
      "details": {
        "url": "https://defra-family.force.com/s/Welcome",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PBHC-6261-BLLQ",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Melanie Swain",
        "email": "melanie.swain@defra.gov.uk"
      }
    },
    {
      "id": "GB-PPON-PNBD-3289-CDGX",
      "name": "DEPARTMENT OF ENVIRONMENT, FOOD AND RURAL AFFAIRS",
      "roles": [
        "procuringEntity"
      ],
      "address": {
        "region": "UKI32",
        "country": "GB",
        "locality": "London",
        "postalCode": "SW1P 4DF",
        "countryName": "United Kingdom",
        "streetAddress": "Seacole Building, 2 Marsham Street"
      },
      "details": {
        "url": "https://defra-family.force.com/s/Welcome"
      },
      "identifier": {
        "id": "PNBD-3289-CDGX",
        "scheme": "GB-PPON"
      },
      "roleDetails": "Defra Group Commercial",
      "contactPoint": {
        "name": "Melanie Swain",
        "email": "melanie.swain@defra.gov.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "047118-2025",
        "url": "https://www.find-tender.service.gov.uk/Notice/047118-2025",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2025-08-08T08:56:20+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2025-09-08T23:59:59+01:00",
        "description": "If your organisation is interested in this requirement, please provide the following information to the named contact above, via email: - The details of your organisation's FMD antigen and vaccine products. - Number and size of dose. - Data on safety, efficacy and period (onset and duration) of immunity in the target species. - Longevity/shelf life of vaccines and antigen. - The number of doses in the vaccination schedule. - Storage conditions and bottle sizes available. - The type of technology used to develop the vaccine production capacity. - Species that can be vaccinated and any data on the minimum age that animals can be vaccinated. - Whether the vaccine is produced to GMP standard or equivalent. - Whether the vaccine is manufactured and stored according to the WOAH Terrestrial Manual Chapter 3.1.8. - Whether the vaccine is currently authorised for use with a valid marketing authorisation and, if so, where is the vaccine authorised. - Whether the vaccine has been used elsewhere in the world. - Timelines for submitting applications for a marketing authorisation to VMD (if relevant). - The likely cost of the product. - Information on novel technologies and products and likely timeframe to market."
      }
    ]
  },
  "initiationType": "tender"
}
Complete JSON history (2 releases)
8 Aug 2025 · 047118-2025 · planning
{
  "id": "047118-2025",
  "tag": [
    "planning"
  ],
  "date": "2025-08-08T08:56:20+01:00",
  "ocid": "ocds-h6vhtk-0583a6",
  "buyer": {
    "id": "GB-PPON-PBHC-6261-BLLQ",
    "name": "ANIMAL AND PLANT HEALTH AGENCY"
  },
  "tender": {
    "id": "P37007",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "hasRenewal": true,
        "suitability": {
          "sme": true
        },
        "contractPeriod": {
          "endDate": "2031-12-31T23:59:59Z",
          "startDate": "2026-04-01T00:00:00+01:00",
          "maxExtentDate": "2036-12-31T23:59:59Z"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33651690",
            "scheme": "CPV",
            "description": "Vaccines for veterinary medicine"
          }
        ]
      }
    ],
    "title": "Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine",
    "value": {
      "amount": 4500000,
      "currency": "GBP",
      "amountGross": 5400000
    },
    "status": "planned",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "Defra is exploring options for supply of antigen and vaccines to the UK foot and mouth disease (FMD) vaccine bank and is seeking to identify existing and potential suppliers who have FMD vaccines with robust evidence of quality, safety, and efficacy. We are keen to hear from suppliers who are in a position to supply suitable FMD vaccine products from early 2027 (including manufacturing lead times as necessary). Please provide the information detailed in the section below, but please note that Defra will not consider heterologous vaccine products. Those wishing to provide the information requested here should contact Melanie Swain (melanie.swain@defra.gov.uk), by the 8 September 2025. Defra reserves the right to follow up with suppliers on a 1:1 basis to further understand their capabilities with regard to this requirement. Defra is seeking this information to inform decisions around guarantees of supply to the UK market. Therefore the estimated total value shown below is only indicative at this stage.",
    "communication": {
      "futureNoticeDate": "2025-11-21T23:59:59Z"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PBHC-6261-BLLQ",
      "name": "ANIMAL AND PLANT HEALTH AGENCY",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI32",
        "country": "GB",
        "locality": "London",
        "postalCode": "SW1P 4DF",
        "countryName": "United Kingdom",
        "streetAddress": "Seacole Building, 2 Marsham Street"
      },
      "details": {
        "url": "https://defra-family.force.com/s/Welcome",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PBHC-6261-BLLQ",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Melanie Swain",
        "email": "melanie.swain@defra.gov.uk"
      }
    },
    {
      "id": "GB-PPON-PNBD-3289-CDGX",
      "name": "DEPARTMENT OF ENVIRONMENT, FOOD AND RURAL AFFAIRS",
      "roles": [
        "procuringEntity"
      ],
      "address": {
        "region": "UKI32",
        "country": "GB",
        "locality": "London",
        "postalCode": "SW1P 4DF",
        "countryName": "United Kingdom",
        "streetAddress": "Seacole Building, 2 Marsham Street"
      },
      "details": {
        "url": "https://defra-family.force.com/s/Welcome"
      },
      "identifier": {
        "id": "PNBD-3289-CDGX",
        "scheme": "GB-PPON"
      },
      "roleDetails": "Defra Group Commercial",
      "contactPoint": {
        "name": "Melanie Swain",
        "email": "melanie.swain@defra.gov.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "047118-2025",
        "url": "https://www.find-tender.service.gov.uk/Notice/047118-2025",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2025-08-08T08:56:20+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2025-09-08T23:59:59+01:00",
        "description": "If your organisation is interested in this requirement, please provide the following information to the named contact above, via email: - The details of your organisation's FMD antigen and vaccine products. - Number and size of dose. - Data on safety, efficacy and period (onset and duration) of immunity in the target species. - Longevity/shelf life of vaccines and antigen. - The number of doses in the vaccination schedule. - Storage conditions and bottle sizes available. - The type of technology used to develop the vaccine production capacity. - Species that can be vaccinated and any data on the minimum age that animals can be vaccinated. - Whether the vaccine is produced to GMP standard or equivalent. - Whether the vaccine is manufactured and stored according to the WOAH Terrestrial Manual Chapter 3.1.8. - Whether the vaccine is currently authorised for use with a valid marketing authorisation and, if so, where is the vaccine authorised. - Whether the vaccine has been used elsewhere in the world. - Timelines for submitting applications for a marketing authorisation to VMD (if relevant). - The likely cost of the product. - Information on novel technologies and products and likely timeframe to market."
      }
    ]
  },
  "initiationType": "tender"
}
7 Aug 2025 · 047030-2025 · planning
{
  "id": "047030-2025",
  "tag": [
    "planning"
  ],
  "date": "2025-08-07T16:17:58+01:00",
  "ocid": "ocds-h6vhtk-0583a6",
  "buyer": {
    "id": "GB-PPON-PBHC-6261-BLLQ",
    "name": "ANIMAL AND PLANT HEALTH AGENCY"
  },
  "tender": {
    "id": "P37007",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "hasRenewal": true,
        "suitability": {
          "sme": true
        },
        "contractPeriod": {
          "endDate": "2031-12-31T23:59:59Z",
          "startDate": "2026-04-01T00:00:00+01:00",
          "maxExtentDate": "2036-12-31T23:59:59Z"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33651690",
            "scheme": "CPV",
            "description": "Vaccines for veterinary medicine"
          }
        ]
      }
    ],
    "title": "Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine",
    "value": {
      "amount": 4500000,
      "currency": "GBP",
      "amountGross": 5400000
    },
    "status": "planned",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "This requirement is for guaranteed access to a stock of antigen for a variety of Foot and Mouth Disease (FMDV) virus strains, and for the production and delivery of vaccine to the UK, should formulated vaccine be required in the event of an FMDV outbreak.",
    "communication": {
      "futureNoticeDate": "2025-11-21T23:59:59Z"
    },
    "aboveThreshold": false,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PBHC-6261-BLLQ",
      "name": "ANIMAL AND PLANT HEALTH AGENCY",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI32",
        "country": "GB",
        "locality": "London",
        "postalCode": "SW1P 4DF",
        "countryName": "United Kingdom",
        "streetAddress": "Seacole Building, 2 Marsham Street"
      },
      "details": {
        "url": "https://defra-family.force.com/s/Welcome",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PBHC-6261-BLLQ",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Melanie Swain",
        "email": "melanie.swain@defra.gov.uk"
      }
    },
    {
      "id": "GB-PPON-PNBD-3289-CDGX",
      "name": "DEPARTMENT OF ENVIRONMENT, FOOD AND RURAL AFFAIRS",
      "roles": [
        "procuringEntity"
      ],
      "address": {
        "region": "UKI32",
        "country": "GB",
        "locality": "London",
        "postalCode": "SW1P 4DF",
        "countryName": "United Kingdom",
        "streetAddress": "Seacole Building, 2 Marsham Street"
      },
      "details": {
        "url": "https://defra-family.force.com/s/Welcome"
      },
      "identifier": {
        "id": "PNBD-3289-CDGX",
        "scheme": "GB-PPON"
      },
      "roleDetails": "Defra Group Commercial",
      "contactPoint": {
        "name": "Melanie Swain",
        "email": "melanie.swain@defra.gov.uk"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "047030-2025",
        "url": "https://www.find-tender.service.gov.uk/Notice/047030-2025",
        "format": "text/html",
        "noticeType": "UK1",
        "description": "Pipeline notice on Find a Tender",
        "documentType": "plannedProcurementNotice",
        "datePublished": "2025-08-07T16:17:58+01:00"
      }
    ]
  },
  "initiationType": "tender"
}